News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Analysts recommend buying Pfizer at $35 with a $50 target, citing cash flow and pipeline catalysts.
  • GitLab recommended long on AI-driven demand and ~42% ARR growth, with a mid-term trade setup.
  • M/I Homes recommended buy based on low leverage, free cash flow, and ~11 P/E.
  • Recommended trades include defined entry, stop, and target levels across 46–180 trading-day horizons.
  • Analyst activity covers pharma, AI-exposed software, and homebuilding, highlighting stock-specific opportunities.
  • Overall sentiment: positive; all hourly recommendations are buy-focused across sectors.

Latest Articles

Lantronix Adds High-Margin ARR and Expands Critical Infrastructure Monitoring Platform with Acquisition of Vecima Networks’ Industrial IoT Business

Lantronix Adds High-Margin ARR and Expands Critical Infrastructure Monitoring Platform with Acquisition of Vecima Networks’ Industrial IoT Business

Lantronix Inc. announced its agreement to acquire Vecima Networks' Industrial IoT business including the Nero Global Tracking SaaS platform. The acquisition adds $5.3 million in total revenue, with $4.5 million in annual recurring revenue and approximately 125,000 asset tags under management, enhancing Lantronix's critical infrastructure monitoring…

APA Corporation Releases 2026 Sustainability Progress Report

APA Corporation Releases 2026 Sustainability Progress Report

APA Corporation released its 2026 Sustainability Progress Report detailing progress on key sustainability priorities during 2025, including emissions performance, water stewardship, employee engagement, and community investment. The report reflects the company's ongoing commitment to responsible operations and advancing sustainability while support…

Quantum Corp CEO Executes $65K Stock Sale Amid Valuation Debate

Quantum Corp CEO Executes $65K Stock Sale Amid Valuation Debate

Quantum Corp (NASDAQ:QMCO) President and CEO Hugues Meyrath completed a $65,498 stock sale on July 2, 2026, to satisfy tax obligations from restricted stock unit vesting. The transaction occurs as the stock trades near $10.13, down from recent highs, while the company navigates a Northland downgrade and reports mixed fiscal fourth-quarter results f…

Privia Health Group CFO David Mountcastle Executes Pre-Planned Stock Sale

Privia Health Group CFO David Mountcastle Executes Pre-Planned Stock Sale

Privia Health Group, Inc. (NASDAQ: PRVA) Executive Vice President and Chief Financial Officer David Mountcastle executed a sale of 24,734 shares of common stock on July 2, 2026, totaling approximately $680,185. The transactions occurred while the stock was trading near its 52-week high of $27.52, with shares up 27% over the past year. The sales wer…

Kura Sushi USA Announces Fiscal Third Quarter 2026 Financial Results

Kura Sushi USA Announces Fiscal Third Quarter 2026 Financial Results

Kura Sushi USA, a technology-enabled Japanese restaurant chain, reported its fiscal third quarter 2026 financial results showing total sales increased to $85.9 million from $74.0 million in Q3 2025. Despite this, comparable restaurant sales slightly decreased by 0.4%. The company improved its restaurant-level operating profit margin to 19.1% and ad…

Howard Hughes Holdings Inc. Announces Dates and Times for 2026 Second Quarter Earnings Release and Conference Call

Howard Hughes Holdings Inc. Announces Dates and Times for 2026 Second Quarter Earnings Release and Conference Call

Howard Hughes Holdings Inc. (NYSE: HHH) announced that it will release its second quarter 2026 earnings on August 5, 2026, after market close, with a conference call scheduled for August 6, 2026 at 10:00 AM Eastern Time. The call will be accessible via live webcast and telephone, with a replay available for one year on the company website.

FuelCell Energy Announces Launch of Offering of Common Stock

FuelCell Energy Announces Launch of Offering of Common Stock

FuelCell Energy, Inc. announced an underwritten public offering of $200 million in common stock to raise capital for expanding manufacturing capacity, supporting growth, and general corporate uses. The offering is subject to market conditions and the company has granted underwriters a 30-day option to purchase additional shares. Citigroup and Barcl…

Nyxoah Announces Preliminary Results for the Second Quarter of 2026

Nyxoah Announces Preliminary Results for the Second Quarter of 2026

Nyxoah SA announced preliminary unaudited second quarter results for 2026, showing a 21% sequential increase in global net revenue to €7.7 million, driven by a 22% rise in U.S. sales. The company has trained more surgeons, activated new accounts, and secured substantial financing totaling $110 million. CMS proposed significant reimbursement increas…

Business First Bancshares, Inc. Acquires American Planning Corporation, Strengthening Community Bank Advisory Services Through Smith Shellnut Wilson

Business First Bancshares, Inc. Acquires American Planning Corporation, Strengthening Community Bank Advisory Services Through Smith Shellnut Wilson

Business First Bancshares, Inc. (Nasdaq: BFST) has acquired American Planning Corporation, a financial consulting firm specializing in community banks. This acquisition strengthens its subsidiary Smith Shellnut Wilson's advisory platform by adding outsourced CFO services, financial modeling, strategic and capital planning, and regulatory consulting…

Vor Bio Appoints David Zaccardelli to Board of Directors

Vor Bio Appoints David Zaccardelli to Board of Directors

Vor Bio, a clinical-stage biotech company focused on autoimmune diseases, announced the appointment of Dr. David Zaccardelli to its Board of Directors. Dr. Zaccardelli brings extensive experience leading biopharma companies through late-stage clinical development, regulatory approvals, and commercialization. Vor Bio is advancing telitacicept, a dua…